Pharmafile Logo
Pharmafocus logo
Advanced Search

menlo therapeutics

Showing 1 posts of 1 posts found.

Menlo Therapeutics’ cough drug fails to meet primary endpoint in phase II trial

October 9, 2018
Manufacturing and Production Phase II, cough, menlo therapeutics, serlopitant

The Redwood City, California-based late stage biopharmaceutical company Menlo Therapeutics have announced that experimental drug serlopitant has failed to meet …

News

Latest content

Sanofi shares results for phase 3 LUNA 3 trial in immune thrombocytopenia

April 23, 2024

FDA approves ImmunityBio’s Anktiva bladder cancer treatment

April 23, 2024

EC approves Pfizer’s Emblaveo for multidrug-resistant infection treatment

April 22, 2024

Neurolentech and Kaerus Bioscience enter partnership for research on neurodevelopmental disorder

April 22, 2024

Ardena announces €20m expansion following first GMP approval

April 19, 2024